chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shortly after receiving my first covid 19 Pfizer vaccine the right side of my face began feeling pins and needles like coming out of the numbing from the dentist. The numb tingling feeling spread to the top of eye lid and head all staying on the right side of my body.  It then spread down to my right arm and hand then my right leg and foot felt numb and tingling.  When the nurse came in to tell me it had been 15 minutes and said I could go I asked her if it was normal for my face to feel numb and tingling.  She had the doctor come in and he spoke with me. There was no sign of swelling or facial drooping. The tingling and numb feeling continued, but there was no sign of respiratory distress or swelling they watched me for another 30 minutes or so and sent me home with instructions to use benadryl or seek medical help if anything else seemed to come about. The numbness and tingling in the entire right side if my body continued until mid day the day after the first immunization.  The doctor  who spoke with me after my first immunization mentioned I could complete this.
Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Headache-Medium, Systemic: Hyperventilation-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Visual Changes/Disturbances-Medium
Facial paralysis; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FACIAL PARALYSIS (Facial paralysis) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 021C21A) for COVID-19 vaccination.     The patient's past medical history included Stroke (one year ago).   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FACIAL PARALYSIS (Facial paralysis) (seriousness criterion medically significant). The patient was treated with PREDNISONE ongoing since an unknown date for Facial paralysis, at a dose of UNK dosage form. At the time of the report, FACIAL PARALYSIS (Facial paralysis) had not resolved.            No relevant concomitant medications were reported.  The reporter stated that patient had no side effects with first dose, 2 or 3 days after receiving second vaccine, patient had a facial paralysis and emergency room  (ER) told him it was due to the vaccine. Patient was treated with prednisone and antiviral medication.  Action taken with mRNA-1273 in response to events was not applicable.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
FEBRILE, TACHYCARDIA, HYPOXIA, HYPERVENTILATION
Pt received seasonal influenza vaccine (uneventful) and then 3 weeks later the novel H1N1 vaccine. The next 48 hours with the H1N1 vaccine pt developed Bell's palsy to (L) face.  Received valacyclovir and prednisone. ```1/15/2010 VA clinic records for 11/29/2009, DX bell's palsy and sinusitis patient with c/o's lt facial paralysis and lt ear pain neuro exam noted decreased sensation, tx'd prednisone/acyclovir
rapid heart rate, 99; palpitations; high blood pressure; This is a spontaneous report from a contactable consumer (patient). A 70-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) via unspecified route of administration in left arm on 13Feb2021 at 15:00 [at the age of 70-year-old] as single dose for COVID-19 immunization at School or Student Health Clinic. Medical history of the patient included Atrial Fibrilation, Congestive heart failure (CHF), Catheter Ablation [21Apr2021, successfully cured], Implanted heart monitor. Patient did not had Covid prior vaccination and was not tested for COVID post vaccination. Patient had no known allergies. Patient did not receive any other vaccination in four weeks and did not receive any other medication [concomitant] within two weeks. On 13Feb2021 at 17:00, within two hours of first dose patient experienced rapid heart rate, 99, palpitations, high blood pressure which lasted about 36 hours. Patient did not receive any treatment in response to the event. Outcome of the event was recovered on an unspecified date in Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a physician refers to an 18 months and 6 days old male patient with no concomitant medication, pertinent medical history or drug reactions/allergies. The patient was vaccinated with first dose of MMR II and (Merck) VARIVAX intramuscularly on unspecified date approximately 3 months ago in April 2012 and developed a localized reaction. No concomitant medications were reported. The patient's mother described the rash as red, raised rash around the injection site, which looked like sores and covered approximately a 5cm area. The patient's mother also mentioned the patient had a 100-101 temperature for 10 days after the administration. The patient's mother did not seek medical attention for the patient. No laboratory diagnostics studies or treatment were performed. The outcome was reported as recovering/resolving. Additional information has been requested.
Unable to keep any food / drink down; severe nausea; Vomiting; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 23-year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administration date May2021 (Batch/Lot number: unknown) at the age of 22 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "tourette syndrome" (unspecified if ongoing), notes: tourette syndrome - mild case; "anxiety" (unspecified if ongoing), notes: anxiety; "depression" (unspecified if ongoing), notes: depression under control with meds; "penicillin - trunk rash" (unspecified if ongoing), notes: known allergies penicillin - trunk rash. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Pfizer COVID 19, lot unknown reason=Not available/provided to reporter at the time of report completion.), administration date: Apr2021, when the patient was 22 years old, for Covid-19 immunization. Prior vaccination, patient did not have covid and not tested for covid post vaccination. The following information was reported: IMPAIRED GASTRIC EMPTYING (medically significant), outcome "not recovered", described as "Unable to keep any food / drink down"; NAUSEA (non-serious), outcome "not recovered", described as "severe nausea"; VOMITING (non-serious), outcome "not recovered", described as "Vomiting". The event "unable to keep any food / drink down" was evaluated at the emergency room visit. Therapeutic measures were taken as a result of impaired gastric emptying, nausea, vomiting. Clinical course: after the 2nd dose and now the booster, reporter daughter has had severe nausea, vomiting and is unable to keep any food / drink down.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Had VARIVAX shot 11-21-07 however contracted chickenpox pustular lesions on erythematous bases post neck. (L) check, (R) hip and pruritis (has had sev. d). Obviously not shot Rx
Right after the vaccine had chills, lethargy, unable to sleep from shivering, coughing violently, symptoms persisted for about a week, body aches. Several weeks later experienced same symptoms but worse, went to the urgent care. Given antibiotics, cough medication, about 5 different.
?Covid toes? like symptoms on the right foot only, started a few days after the first vaccine, went away within days. Then a few days after the second dose again and more severely - purple/blue  middle and second toes, painful snd tingly, I had difficulty walking and/or wearing shoes for about a week. I took aspirin daily and anti histamines because I read a case study where they hypothesized that it could be micro blood clots  and treated the patient with anti-coagulants. Didn?t think at the time that it was serious enough to report to my primary care physician but I think I should have. I still have dark patches of skin on those toes.  Here?s the paper I read:   ?Blue toes? following vaccination with the BNT162b2 mRNA COVID-19 vaccine
got up in the morning with a pounding in her ear; face became numb; stuttering badly; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2), administration date 01Mar2021 (Lot number: EN6198) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious) with onset 04Mar2021, outcome "unknown", described as "got up in the morning with a pounding in her ear"; HYPOAESTHESIA (non-serious) with onset 04Mar2021, outcome "unknown", described as "face became numb"; DYSPHEMIA (non-serious) with onset 04Mar2021, outcome "unknown", described as "stuttering badly". The events "got up in the morning with a pounding in her ear", "face became numb" and "stuttering badly" were evaluated at the physician office visit. Additional information: Course of events was described as follows: The patient had her first Pfizer vaccine on 01Mar21 and she did not had a reaction that day but on 04Mar2021, Thursday of the same week, she got up in the morning with a pounding in her ear and her face became numb and she was stuttering badly, which she does not normally do. Patient went to the doctor and he said he did not think that it was a reaction to the vaccine because it was outside of the normal 48 hours timeframe in which it normally appears. The reporter was querying if it was wise for the patient to get the second dose which was supposed to be today, this morning.  No follow-up attempts are possible. No further information is expected.
Left thigh with reaction. Firm, hot to touch, red, large area covering anterior thigh from hip to approximately 3 inches proximal to knee.
Patient received flu shot and was told to stick around store for about 15 mins. About a half hour after vaccine administered, patient called saying he felt "weird in head", faint, and short of breath. Patient said he was closer to ER than store so he was heading to ER.
pt brought to ED with increasing SOB, chills, N/V, cough; pt was hypertensive, tachycardic, tachypnic; NRB; positive for COVID; DKA, AKI, hyponatremia; pt suffered cardiac arrest; CPR; intubated; after 25 minutes of resuscitation, pt expired
PENTACEL was not mixed with diluent. Patient instructed to come back for separate HIB.
Narrative: Pt presented to ED with chest tightness and SOB that started morning after his 3rd dose. EKG was normal. He is currently experiencing a sensation of chest pressure in the middle of his sternum, he denies any neck or arm pain, no nausea, vomiting or diaphoresis. He feels slightly short of breath 2/2 chest pressure, not related to exertion. He has no cough or sputum production. Denies any fevers or chills. 71 year old male who presents with chest pressure and shortness of breath. Reassuring that his EKG is unchanged. Delta trop negative. Physical exam was also unrevealing. Overall seems pt's symptoms most consistent with post-vaccination physioloic response.
Initially tiredness, then seemed ok for a while, then 3/30 had 2.5 drinks (wine / beer). 3/31 wicked hangover. Still lightheaded, low blood pressure, slight head ache, some concentration problems. Some BP readings: 95 \57 Pulse 66, 87/55 P54, 92\57 P64, 102/61 P61, 84/67 P57, 103\55 p60, 102/62 p62).  My normal BP is low (like 110 / 70), but not that low.
Dystonia, a neuromuscular disorder is a genetic condition that runs in our family.  Prior to the injection, I did not have any symptoms of Dystonia.  Since the injection, I have had two symptoms.  Both began about 2 weeks after the J&J injections.  Eye twitching of the right eye and foot cramping of both feet.  The eye twitching (closing) continues today.  The foot cramping has ceased or is not present at this time.
This initial spontaneous case, initially received on 06-OCT-2017, reported by other health professional and concerns a 19-year-old female patient. Patient's medical history and concomitant medications were not reported. On 06-Oct-2017, the patient received AFLURIA QUADRIVALENT, which was in the refrigerator and the refrigerator temperature was 37 to 35 degrees with the lowest being at 12 degrees for 1 minute (dose: 0.5 ml, batch number: XF33308, route of administration: intramuscular, anatomical location: left deltoid). Not sure if it was the probe that has the problem or the refrigerator. Patient received vaccine that underwent temperature excursion. It was reported that, the patient did not experience any adverse event after the administration of the vaccine. The reporter assessed this case as non-serious. Follow up report received on 17-Oct-2017: The route of administration (intramuscular), anatomical location (left deltoid) were updated. It was reported that, the patient did not experience any adverse event after the administration of the vaccine. The narrative was amended accordingly. Insignificant case correction received with IRD 06-OCT-2017: The description as reported for the event drug administration error was changed from "AFLURIA QUADRIVALENT was in the refrigerator and the refrigerator went from 37 to 35 with the lowest being at 12 degrees for 1 minute/Patient received vaccine that underwent temperature excursion" to "patient received vaccine that underwent temperature excursion". The description as reported for event product storage error was changed from AFLURIA QUADRIVALENT was in the refrigerator and the refrigerator went from 37 to 35 with the lowest being at 12 degrees for 1 minute/Patient received vaccine that underwent temperature excursion "to" AFLURIA QUADRIVALENT was in the refrigerator and the refrigerator went from 37 to 35 with the lowest being at 12 degrees for 1 minute/[Patient received vaccine] that underwent temperature excursion".
Headache; muscle aches; fatigue; This is a spontaneous report from a non-contactable consumer (patient herself). A 47-year-old non-pregnant female patient who received the first dose of BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number EL3247, Expiration date unknown), via an unspecified route of administration on 04Feb2021 at 11:00, administered in left arm, at single dose for covid-19 immunization (at the age of 47-years) in clinic. Patient did not pregnant at the time of vaccination. Patient's medical history included hypertension, GERD (Gastrooesophageal reflux disease), and obesity. Patient's concomitant medications included labetalol, Losartan, and HCTZ (hydrochlorothiazide) within 2 weeks of vaccination. The patient had Keflex allergy to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. On 05Feb2021, the patient experienced headache, muscle aches and fatigue. The patient did not receive any treatment for the events. The outcome of events was not recovered on an unspecified date.
Covid Moderna booster given by LPN was given to patient who is 17 years and 8 months. No adverse effect noted.
flushing; lightheadedness; chills; tongue numbness; dry mouth; cold hands and feet; This is a spontaneous report from a contactable physician (patient herself). A 67-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EK9231), via an unspecified route of administration on 24Dec2020 13:15 in left arm at single dose for covid-19 immunization. Medical history included none. The patient was not allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included methylphenidate hydrochloride (RITALIN) and one-a-day ascorbic acid, ergocalciferol, nicotinamide, retinol, riboflavin, thiamine hydrochloride (VITAMINS), both from Dec2020 for an unspecified indication. Immediately after vaccine, patient experienced flushing, then lightheadedness, and waves of flushing and chills every minute for several hours; tongue numbness, dry mouth, cold hands and feet; no rash, no breathing difficulty - normal vital signs on 24Dec2020 13:30. Patient received iv diphenhydramine hydrochloride (BENADRYL) and famotidine (PEPCID) and iv hydration after symptoms were not improving 3 hours later - several hours after this treatment, the flushing and chills continued, as did numbness of tongue and dry mouth. Symptoms were still present 22 hours after injection-waves of flushing and chills. The events were reported as non-serious and the events resulted in Emergency room/department or urgent care. Outcome of events were not recovered.
pt recvd flu vax devel GBS; as of the date of this report pt still has residual paralysis of rt foot & leg;
Patient stated a couple days after first dose, he noticed redness of arm going from injection site down towards elbow area. he stated his arm was extremely itchy. he denied it being warm to touch. patient used a moisturizing cream and stated redness and itching resolved on it's own
Initial unsolicited report received from a consumer on 16-May-2016. This case involves a 12-months-old (reported as one year old) female patient (who was vaccinated with a first dose of Diphtheria/Tetanus (batch number: unknown, expiry date, route and site of administration: not reported) on an unspecified date in around 1941. Patient denied illness at time of vaccination. Pre-existing physician diagnosed allergies, birth defects, medical conditions was reported as Diptheria. Concomitant medications were not reported. On an unspecified date, following the vaccination, the patient had swelled all up. It was reported that since then, the patient took only Tetanus containing vaccine as told by the doctor. On an unspecified date, the patient required emergency room/doctor visit. Laboratory investigations and corrective treatment was not reported. On an unspecified date, the patient recovered from the event. List of documents held by sender: none.
Fever, Chills, Aches, Pains lasting 12-18 hours
rash consistent with shingles, T4 dermatome, on same side, with muscle pain
hives; This is a spontaneous report from a contactable Nurse. A patient of unspecified age and gender received the first dose of meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced hives on an unspecified date. The nurse reported that  the patient developed hives after first dose of meningococcal group b rlp2086 vaccine. The doctor asked the nurse to contact the vaccine manufacturer to seek advice on whether or not this patient should receive the second dose of meningococcal group b rlp2086 or not. The outcome of the event was unknown.   No follow-up attempts are needed, Information on Lot/Batch number cannot be obtained.
unprovoked blood clots; This is a spontaneous report from a contactable other HCP. A 73 year old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left at age of 72 years old on 04Feb2021 09:00 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Pregnancy at time of Vaccination: No. Medical history included hypertension (HBP), sleep apnoea, osteoporosis. No covid prior vaccination. Concomitant medication(s) included calcium (CALCIUM) taken for an unspecified indication, start and stop date were not reported; colecalciferol (VITAMIN D) taken for an unspecified indication, start and stop date were not reported; hydrochlorothiazide, losartan potassium (LOSARTAN HCT) taken for an unspecified indication, start and stop date were not reported.  The patient previously received first dose of bnt162b2 at age of 72 years old 14Jan2021 08:00 AM arm left for covid-19 immunisation, took dimerol and experienced drug allergy. The patient experienced unprovoked blood clots on 16Jun2021 02:30 AM for which patient was hospitalized for 3 days. Treatment included blood thinner. The patient underwent lab tests and procedures which included covid test type post vaccination=Blood test: negative on 16Jun2021. Outcome of event was recovered in 2021. Event was resulted in: [Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event)].  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Considering the temporal association, a causal association between administration of bnt162b2 and the onset of unprovoked blood clots cannot be excluded. The history of hypertension may provide an explanation.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Pain, redness, swelling at injection site. Fever, malaise. Took Acetaminophen and Ibuprofen.
Deep body aches and fatigue.  Not sure if related but only thing that I have done differently is have a vaccine. My second Moderna vaccine was on 3/6/21
Facial dermatitis; Dry skin; increased facial wrinkles; pain; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 38 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 20Oct2021 15:30 (Lot number: FF8839) at the age of 38 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; B COMPLEX [VITAMIN B COMPLEX]. Vaccination history included: Bnt162b2 (DOSE 1, Lot No: EJ1685, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 18Dec2020, when the patient was 37 years old, for COVID-19 Immunization; Bnt162b2 (DOSE 2), administration date: 05Jan2021, when the patient was 37 years old, for COVID-19 Immunization. The following information was reported: DERMATITIS (non-serious) with onset 21Oct2021 08:00, outcome "not recovered", described as "Facial dermatitis"; DRY SKIN (non-serious) with onset 21Oct2021 08:00, outcome "not recovered", described as "Dry skin"; SKIN WRINKLING (non-serious) with onset 21Oct2021 08:00, outcome "not recovered", described as "increased facial wrinkles"; PAIN (non-serious) with onset 21Oct2021 08:00, outcome "not recovered", described as "pain".  Additional information: The patient was not diagnosed with Covid-19, prior to vaccination and has not been tested for Covid-19 since the vaccination. The patient not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no known allergies.  No follow-up attempts are possible. No further information is expected.